These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 28623419

  • 1. Droxidopa for symptomatic neurogenic orthostatic hypotension: what can we learn?
    Kaufmann H.
    Clin Auton Res; 2017 Jul; 27(Suppl 1):1-3. PubMed ID: 28623419
    [No Abstract] [Full Text] [Related]

  • 2. Titrating droxidopa to maximize symptomatic benefit in a patient with Parkinson disease and neurogenic orthostatic hypotension.
    Gupta F, Karabin B, Mehdirad A.
    Clin Auton Res; 2017 Jul; 27(Suppl 1):15-16. PubMed ID: 28699047
    [No Abstract] [Full Text] [Related]

  • 3. Droxidopa (Northera) for neurogenic orthostatic hypotension.
    Med Lett Drugs Ther; 2015 Jun 22; 57(1471):92-3. PubMed ID: 26079764
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Initiating droxidopa for neurogenic orthostatic hypotension in a patient with Parkinson disease.
    Claassen D, Lew M.
    Clin Auton Res; 2017 Jul 22; 27(Suppl 1):13-14. PubMed ID: 28631224
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Managing supine hypertension in a patient with non-diabetic autonomic neuropathy receiving droxidopa for neurogenic orthostatic hypotension.
    Vernino S, Lew M, Kremens D.
    Clin Auton Res; 2017 Jul 22; 27(Suppl 1):35-37. PubMed ID: 28623420
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Polypharmacy: droxidopa to treat neurogenic orthostatic hypotension in a patient with Parkinson disease and type 2 diabetes mellitus.
    Vernino S, Claassen D.
    Clin Auton Res; 2017 Jul 22; 27(Suppl 1):33-34. PubMed ID: 28674868
    [No Abstract] [Full Text] [Related]

  • 10. Adding droxidopa to fludrocortisone or midodrine in a patient with neurogenic orthostatic hypotension and Parkinson disease.
    Kremens D, Lew M, Claassen D, Goodman BP.
    Clin Auton Res; 2017 Jul 22; 27(Suppl 1):29-31. PubMed ID: 28674867
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Differential diagnosis of suspected neurogenic orthostatic hypotension in a patient with Parkinson disease.
    Lew M, Kremens D.
    Clin Auton Res; 2017 Jul 22; 27(Suppl 1):5-7. PubMed ID: 28674866
    [No Abstract] [Full Text] [Related]

  • 13. Droxidopa as an effective treatment for refractory neurogenic orthostatic hypotension and reflex bradycardia in amyloid light-chain amyloidosis: a case report.
    Ho AH, Kinter CW, Wight J, Neelam AR, Krakow D.
    J Med Case Rep; 2020 Jun 20; 14(1):73. PubMed ID: 32560740
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cardiovascular Safety of Droxidopa in Patients With Symptomatic Neurogenic Orthostatic Hypotension.
    White WB, Hauser RA, Rowse GJ, Ziemann A, Hewitt LA.
    Am J Cardiol; 2017 Apr 01; 119(7):1111-1115. PubMed ID: 28159196
    [Abstract] [Full Text] [Related]

  • 16. Droxidopa for the short-term treatment of symptomatic neurogenic orthostatic hypotension in Parkinson's disease (nOH306B).
    Hauser RA, Isaacson S, Lisk JP, Hewitt LA, Rowse G.
    Mov Disord; 2015 Apr 15; 30(5):646-54. PubMed ID: 25487613
    [Abstract] [Full Text] [Related]

  • 17. Droxidopa reduces postural sway in Parkinson disease patients with orthostatic hypotension.
    Marsili L, Duque KR, Sturchio A, Sobrero G, Premoli I, Dwivedi AK, Espay AJ, Merola A.
    Parkinsonism Relat Disord; 2022 Jun 15; 99():62-64. PubMed ID: 35605513
    [Abstract] [Full Text] [Related]

  • 18. Droxidopa and Reduced Falls in a Trial of Parkinson Disease Patients With Neurogenic Orthostatic Hypotension.
    Hauser RA, Heritier S, Rowse GJ, Hewitt LA, Isaacson SH.
    Clin Neuropharmacol; 2016 Jun 15; 39(5):220-6. PubMed ID: 27332626
    [Abstract] [Full Text] [Related]

  • 19. Cost-effectiveness of droxidopa in patients with neurogenic orthostatic hypotension: post-hoc economic analysis of Phase 3 clinical trial data.
    François C, Hauser RA, Aballéa S, Dorey J, Kharitonova E, Hewitt LA.
    J Med Econ; 2016 Jun 15; 19(5):515-25. PubMed ID: 26710315
    [Abstract] [Full Text] [Related]

  • 20. Droxidopa in patients with neurogenic orthostatic hypotension associated with Parkinson's disease (NOH306A).
    Hauser RA, Hewitt LA, Isaacson S.
    J Parkinsons Dis; 2014 Jun 15; 4(1):57-65. PubMed ID: 24326693
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.